48
Participants
Start Date
December 31, 2005
Primary Completion Date
June 30, 2014
Study Completion Date
June 30, 2014
filgrastim
Given subcutaneously
doxorubicin hydrochloride
Given IV
etoposide
Given IV
ifosfamide
Given IV
conventional surgery
Patients undergo surgery
radiation therapy
Patients undergo radiotherapy
Children's Hospital of Pittsburgh, Pittsburgh
Children's Hospital of Philadelphia, Philadelphia
Pennsylvania Oncology Hematology Associates, Philadelphia
Carolinas Hematology-Oncology Associates, Charlotte
UAB Comprehensive Cancer Center, Birmingham
University of Iowa Hospitals and Clinics, Iowa City
University of Minnesota, Minneapolis
Children's Memorial Hospital - Chicago, Chicago
Huntsman Cancer Institute at University of Utah, Salt Lake City
Sarcoma Oncology Center, Santa Monica
Seattle Cancer Care Alliance at Washington University, Seattle
Indiana University, Indianapolis
Johns Hopkins, Baltimore
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office, Bethesda
University of Michigan Comprehensive Cancer Center, Ann Arbor
Cincinnati Children's Hospital Medical Center, Cincinnati
M. D. Anderson Cancer Center at University of Texas, Houston
National Cancer Institute (NCI)
NIH
Sarcoma Alliance for Research through Collaboration
OTHER